By using a mouse model composed of tumor cells and endosialin-expressing endothelial cells, Li et al. demonstrated that the endosialin antibody MORAb-004 could inhibit tumor angiogenesis, indicating that endosialin was involved in tumor vasculature 57. This evidence concerns the gene CD248 and neoplasm.